
- Volume 0 0
FDA APPROVES NEW SPARKLE FOR Rx DRUGS
The FDA has approved new pharmaceutical pigmentation rules that arelikely to give extra sparkle to the pills and tablets dispensed by Americanpharmacists. Under the new regulations, manufacturers will be allowed touse "pearlescent pigments" in virtually all oral human drugs, includingtablets, pills, and liquids. Similar to the coloring agents used in many cosmetics,the new pigments can produce metallic or satiny finishes on drugsand can even be used to provide extra coloring.
The pigments are made by coating the mineral mica with either titaniumdioxide or iron oxide—substances used to add luster to everything fromlipstick to automobile paint. Under the new rules, the pigments cannotmake up more than 3% of the weight of a drug.
According to the FDA, "there is no toxic potential when [pigments are]ingested at levels estimated by the agency."
Articles in this issue
over 19 years ago
Pharmacy Technology Productsover 19 years ago
Tobacco Useover 19 years ago
Rx Product Newsover 19 years ago
OTC Product Newsover 19 years ago
can you READ theseRxs?over 19 years ago
Generic Times Product Newsover 19 years ago
compoundingHOTLINEover 19 years ago
Compounding for Pediatric Patientsover 19 years ago
Vaccinations: Current Research and Perceptionsover 19 years ago
Police and Drug TestingNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
















































































































































































































